Consolidated Statement of Changes in Net Equity

Balance as of January 1, 2013

397.2

168.0

3,813.7

5,383.9

–645.3

1.2

–29.5

1,272.2

10,361.4

53.4

10,414.8

Profit after tax

–

–

–

266.0

–

–

–

–

266.0

3.0

269.0

Other compre­hensive income

–

–

–

–

–73.1

0.3

–17.0

19.2

–70.6

1.8

–68.8

Compre­hensive income

–

–

–

266.0

–73.1

0.3

–17.0

19.2

195.4

4.8

200.2

Dividend payments

–

–

–

–

–

–

–

–

–

–1.9

–1.9

Profit transfers to/from E. Merck KG including changes in reserves

–

–

–

–

–

–

–

–

–

–

–

Transactions with no change
of control

–

–

–

2.1

–

–

–

–

2.1

–2.1

–

Changes in scope of consolidation/Other

–

–

–

0.2

–

–

–

–

0.2

–0.2

–

Balance as of March 31, 2013¹

397.2

168.0

3,813.7

5,652.1

–718.4

1.5

–46.5

1,291.4

10,559.0

54.0

10,613.0

Balance as of January 1, 2014

397.2

168.0

3,813.7

6,090.1

–562.7

1.0

44.2

1,068.5

11,020.0

49.2

11,069.2

Profit after tax

–

–

–

325.2

–

–

–

–

325.2

2.2

327.4

Other compre­hensive income

–

–

–

–

–134.5

0.9

–28.2

7.7

–154.1

2.9

–151.2

Compre­hensive income

–

–

–

325.2

–134.5

0.9

–28.2

7.7

171.1

5.1

176.2

Dividend payments

–

–

–

–

–

–

–

–

–

–2.6

–2.6

Profit transfers to/from E. Merck KG including changes in reserves

–

–

–

–

–

–

–

–

–

–

–

Transactions with no change of control

–

–

–

0.3

–

–

–

–

0.3

–0.3

–

Changes in scope of consolidation/Other

–

–

–

–

–

–

–

–

–

–

–

Balance as of March 31, 2014

397.2

168.0

3,813.7

6,415.6

–697.2

1.9

16.0

1,076.2

11,191.4

51.4

11,242.8